new glp 1 gip GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP-1 + GIP Injections -
Description
95% CI, 0.58-0.72)
GLP-1 (glucagon-like peptide-1) receptor agonists are medications used primarily to treat type 2 diabetes and support weight loss
-1775582746855.png&w=3840&q=75)
These effects are greater than those seen with older weight loss medications (typically ~5% total weight loss) and close to typical weight loss seen with bariatric surgery
In addition, primary culture cells are extracted from males or mixed cells from males and females
One limitation of our study is the absence of a lean/pair-fed Bbs5 / group, which could have clarified whether the observed effects in ciliopathies are secondary to obesity
